BIOMARIN PHARMACEUTICAL INC (BMRN)

US09061G1013 - Common Stock

63.45  +0.89 (+1.42%)

After market: 63.45 0 (0%)

Buy % Consensus

79

ChartMill assigns a Buy % Consensus number of 79% to BMRN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 103.34. This target is 62.86% above the current price.
BMRN was analyzed by 35 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about BMRN.
In the previous month the buy percentage consensus was at a similar level.
BMRN was analyzed by 35 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 63.4572.7294.86103.34145.95 - 14.61% 49.50% 62.86% 130.02%
Up and Down Grades
Date Firm Action Rating
2024-11-15 Wolfe Research Initiate Outperform
2024-10-30 Cantor Fitzgerald Maintains Overweight -> Overweight
2024-10-30 William Blair Downgrade Outperform -> Market Perform
2024-10-30 UBS Maintains Buy -> Buy
2024-10-30 RBC Capital Reiterate Sector Perform -> Sector Perform
2024-10-30 Evercore ISI Group Maintains Outperform -> Outperform
2024-10-30 JP Morgan Maintains Overweight -> Overweight
2024-10-30 Baird Maintains Neutral -> Neutral
2024-10-30 Canaccord Genuity Maintains Hold -> Hold
2024-10-30 Citigroup Maintains Neutral -> Neutral
2024-10-10 Raymond James Reiterate Outperform
2024-10-04 RBC Capital Maintains Sector Perform -> Sector Perform
2024-10-04 Barclays Maintains Overweight -> Overweight
2024-09-17 Bernstein Maintains Outperform -> Outperform
2024-09-17 ScotiaBank Maintains Sector Perform -> Sector Perform
2024-09-17 RBC Capital Maintains Sector Perform -> Sector Perform
2024-09-17 Stifel Maintains Buy -> Buy
2024-09-17 Wells Fargo Maintains Overweight -> Overweight
2024-09-17 Truist Securities Maintains Buy -> Buy
2024-09-17 B of A Securities Maintains Buy -> Buy
2024-09-13 Canaccord Genuity Maintains Hold -> Hold
2024-09-09 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-09-05 ScotiaBank Maintains Sector Perform -> Sector Perform
2024-09-05 RBC Capital Reiterate Sector Perform -> Sector Perform
2024-09-05 Truist Securities Maintains Buy -> Buy
2024-09-05 JP Morgan Maintains Overweight -> Overweight
2024-09-05 Piper Sandler Maintains Overweight -> Overweight
2024-08-27 Piper Sandler Maintains Overweight -> Overweight
2024-08-21 Stifel Maintains Buy -> Buy
2024-08-20 Bernstein Upgrade Market Perform -> Outperform